• Primary care may under-recognize patients at risk for NASH

    3 monthes ago - By Healio

    SAN DIEGO - Those at risk for nonalcoholic steatohepatitis, or NASH, may be under-recognized in primary care, according to study findings presented at Digestive Disease Week.
    “Nonalcoholic fatty liver disease affects 80 million Americans and is associated with metabolic syndrome,” Namphuong Tran, MD, of California Pacific Medical Center, San Francisco, and colleagues wrote. “Patients with NAFLD and NASH can be clinically asymptomatic as they progress to cirrhosis; early identification is essential for preventing disease progression.”
    Researchers conducted a
    Read more ...

     

  • CoQ10 found to reverse the effects of fatty liver disease

    CoQ10 found to reverse the effects of fatty liver disease

    3 monthes ago - By Natural News

    Coenzyme Q10, also referred to as CoQ10, is a potent antioxidant naturally produced by the body. According to studies, CoQ10 supplementation is effective in addressing various health problems, such as nonalcoholic fatty liver disease. It can also help reverse the effects of NAFLD. NAFLD is a group of conditions characterized by liver fat...
    Read more ...